| (210) | Number of the EPO application | 19764856 |
| (220) | Filing date of the EPO application | 2019.03.04 |
| (80) | EPO patent specification publication (B) | EPB nr. 52/2025, 2025.12.24 |
| (110) | EPO patent number | 3762015 |
| (11) | Number of the document | MD 3762015 T2 |
| (21) | Number of the application | e 2021 0064 |
| (71) | Name(s) of applicant(s), code of the country | JANSSEN BIOTECH INC., US; |
| (72) | Name(s) of inventor(s), code of the country | CHAN Daphne, US;
ADEDOKUN Omoniyi, US;
CHEN Yang, US;
SZAPARY Philippe, US; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN BIOTECH INC., US; |
| (54) | Title of the invention | Guselkumab for use in the treatment of crohn's disease with a dosage regimen |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 38/17 (2006.01.01); A61K 39/395 (2006.01.01); A61P 1/00 (2006.01.01); C07K 14/54 (2006.01.01); C07K 16/24 (2006.01.01) |
| (52) | Cooperative Patent Classification | A61K 38/1793 (EP); A61P 1/00 (EP); A61P 37/06 (EP); C07K 16/244 (EP) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.02.28 |
| (49) | Date of publication of the translation of the validated European patent specification | 2026.04.30 |
| (30) | Priority | 201862638624 P, 2018.03.05, US |
| (74) | Patent attorney | (Procedură) GLAZACEVA Galina, str. Ghioceilor nr.1, MD-2008, Chişinău, Republica Moldova |
| (86) | International application | PCT/IB2019/051732, 2019.03.04 |
| (87) | International publication | WO 2019/171252, 2019.09.12 |